Hedges Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
+10,100
New +$264K 0.16% 101
2023
Q4
Sell
-6,700
Closed -$222K 111
2023
Q3
$222K Buy
+6,700
New +$237K 0.19% 96
2023
Q1
Sell
-4,000
Closed -$205K 109
2022
Q4
$205K Buy
+4,000
New +$192K 0.18% 97
2022
Q3
Sell
-4,000
Closed -$209K 104
2022
Q2
$209K Hold
4,000
0.2% 95
2022
Q1
$207K Hold
4,000
0.16% 106
2021
Q4
$236K Buy
+4,000
New +$198K 0.18% 110

Other funds holding PFE

Hedges Asset Management's PFE Position: Q2 2026 in Review

Hedges Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 10,100 shares worth $243K. The stake represents 0.16% of the portfolio and ranks #101 among its holdings. This is a return to the name: Hedges Asset Management previously reported a position in PFE as recently as Q3 2023.

Hedges Asset Management first reported a position in PFE in Q4 2021 and has held it in 6 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hedges Asset Management held 10,100 shares of Pfizer worth $243K as of Q2 2026.
  • Pfizer was a new Hedges Asset Management position in Q2 2026.
  • Pfizer made up 0.16% of Hedges Asset Management's portfolio in Q2 2026, its #101 holding.
  • Hedges Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 6 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hedges Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.